Medicare Rx Card Pricing Complexity Is Learning Experience For CMS, Consultant Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS will become more “savvy” in comparing drugs by the time its Part D regulations are drafted, Health Strategies Consultancy’s Mendelson says. Medco settlement agreement will also influence regs, he says.